Onyx will acquire Proteolix and its blood cancer drug candidate in deal worth up to $851M (Minneapolis-St. Paul Star Tribune). NEW YORK – Onyx Pharmaceuticals Inc. Read the rest here: Onyx will acquire Proteolix and its blood cancer
07:05 AM Eastern Daylight Time, 10/12/2009 (MidnightTrader) — Onyx Pharmaceuticals (ONXX) announced that it has signed a definitive agreement to acquire Proteolix, Inc., a privately held biopharmaceutical company focused on discovering 
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment